An intranasally administered IgM protects against antigenically distinct subtypes of influenza A viruses
Abstract Engineering broadly neutralizing monoclonal antibodies (mAbs) targeting the hemagglutinin (HA) of Influenza A virus (IAV) is a promising approach for intervention of seasonal flu. However, HA plasticity often leads to resistant strains that compromise mAb potency as bivalent IgGs. Here we h...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Portfolio
2025-04-01
|
| 叢編: | Nature Communications |
| 在線閱讀: | https://doi.org/10.1038/s41467-025-59294-0 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|
